Jul 2, 2026 01:10AM
Jun 30, 2026 01:09AM
Jun 30, 2026 01:09AM
Jun 18, 2026 01:00AM
Jun 18, 2026 01:00AM
Jun 11, 2026 01:05AM
Jun 11, 2026 01:05AM FDA Grants Priority Review for Genentech’s Tecentriq for a Certain Type of Stage III Colon Cancer
Jun 2, 2026 07:00AM
Jun 2, 2026 01:05AM
May 19, 2026 01:05AM
May 19, 2026 01:05AM
May 15, 2026 12:45PM
May 15, 2026 12:45PM
Apr 30, 2026 01:00AM Genentech to Present Extensive Data Showcasing Its Industry-Leading Ophthalmology Portfolio at ARVO 2026
Apr 22, 2026 08:30AM
Apr 21, 2026 07:15PM
Apr 21, 2026 11:45AM
Apr 21, 2026 01:00AM
Apr 16, 2026 07:00AM
Mar 30, 2026 09:01AM
Mar 30, 2026 09:00AM Roche receives FDA 510(k) clearance for cobas® c703 and cobas® ISE neo, next-generation analytical units enhancing efficiency and capability for laboratories
Mar 18, 2026 09:00AM
Mar 9, 2026 02:10AM
Mar 6, 2026 08:45AM
Mar 2, 2026 01:10AM
Feb 20, 2026 02:00AM
Feb 20, 2026 02:00AM
Feb 20, 2026 01:05AM FDA Accepts New Drug Application for Genentech’s Giredestrant in ESR1-Mutated, ER-Positive Advanced Breast Cancer
Feb 16, 2026 01:00AM
Feb 7, 2026 03:40PM
Dec 22, 2025 01:01AM
Dec 22, 2025 01:00AM
Dec 16, 2025 08:30AM
Dec 8, 2025 04:30PM
Nov 10, 2025 01:10AM Genentech’s Fenebrutinib Shows Unprecedented Positive Phase III Results as the Potential First and Only BTK Inhibitor in Both Relapsing and Primary Progressive Multiple Sclerosis
Nov 3, 2025 09:00AM
Nov 3, 2025 01:00AM
Oct 28, 2025 02:00AM
Oct 23, 2025 09:00AM
Oct 20, 2025 01:05AM
Oct 20, 2025 01:01AM
Oct 20, 2025 01:00AM FDA Approves Genentech’s Gazyva for the Treatment of Lupus Nephritis
Oct 16, 2025 11:49AM
Oct 16, 2025 11:45AM
Oct 13, 2025 09:00AM
Oct 13, 2025 01:05AM
Oct 2, 2025 06:30PM
Oct 2, 2025 06:30PM
Sep 24, 2025 02:30AM Genentech Presents New Data for Ocrevus and Fenebrutinib Across Broad Patient Populations at ECTRIMS 2025
Sep 18, 2025 10:00AM

324,764 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All